Mitsubishi Corporation: Establishment of PeptiGrowth Inc. for Development and Commercialization of Peptide Alternatives to Growth Factors for Cell Culture
- Written by ACN Newswire
TOKYO, Mar 13, 2020 - (JCN Newswire) - Mitsubishi Corporation (MC) and PeptiDream Inc. have agreed to establish a joint venture company that will develop, produce and sell peptide(1) alternatives to growth factors, key ingredients of cell culture(2) used in the manufacturing of cell therapy, regenerative medicines and other biopharmaceuticals.The...